Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
34 hedge funds and large institutions have $6.86M invested in Acer Therapeutics Inc in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 17 reducing their positions, and 11 closing their positions.
49% more capital invested
Capital invested by funds: $4.59M → $6.86M (+$2.27M)
8% less funds holding
Funds holding: 37 → 34 (-3)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
71% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$448K |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$159K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$68K |
| 4 |
Jane Street
New York
|
+$52.4K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$47.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$629K |
| 2 |
State Street
Boston,
Massachusetts
|
-$337K |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$109K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$101K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$80.5K |
ACER Hedge Fund Activity: Q2 2020 in Review
34 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2020, worth a combined $6.86M — up 49% from $4.59M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ACER and 8 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 5 added.
The largest buyer was Worth Venture Partners, opening a new position worth an estimated $448K. The largest seller was BlackRock, cutting an estimated $629K.
- 34 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2020, down from 37 in Q1 2020.
- Funds reported $6.86M of Acer Therapeutics Inc stock for Q2 2020, up 49% quarter-over-quarter.
- 8 funds opened new Acer Therapeutics Inc positions in Q2 2020 and 11 closed out, a net change of -3 holders.
- The largest Acer Therapeutics Inc buyer in Q2 2020 was Worth Venture Partners, an estimated $448K added.
- The largest Acer Therapeutics Inc seller in Q2 2020 was BlackRock, an estimated $629K sold.
Based on aggregated 13F filings for Q2 2020.